Certara stock.

The estimated Net Worth of Richard M. Traynor is at least $10.2 Million dollars as of 6 March 2023. Mr Traynor owns over 10,000 units of Certara stock worth over $4,562,422 and over the last 2 years he sold CERT stock worth over $5,603,360.11 Jan 2022 ... Get Certara Inc (CERT.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.The Nasdaq Stock Market LLC Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing …Certara became a member of the Nasdaq after an upsized initial public offering of its 29,055,000 shares of Class A common stock at $23 per share. Through the IPO, the company raised $316.3 million ...Contact Us U.S. markets open in 9 hours 29 minutes S&P Futures 4,574.25 -2.50(-0.05%) Dow Futures 36,033.00 +23.00(+0.06%) Nasdaq Futures 15,955.50 -30.00(-0.19%) …

Feb 2, 2022 · Certara went public in December 2020, raising $337 million in an IPO. The firm sells biosimulation software and related services to biopharmaceutical firms and regulatory agencies worldwide. CERT ...

Success is Achieved Together. Biosimulation can reduce the size of and cost of human trials, the most expensive and time-consuming part of drug development. In some cases, we can eliminate certain human trials completely. More than 2,000 customers worldwide choose us as their partner for biosimulation software and technology-driven services. The estimated Net Worth of Richard M. Traynor is at least $8.76 Million dollars as of 11 May 2023. Mr Traynor owns over 5,000 units of Certara stock worth over $2,938,988 and over the last 3 years he sold CERT stock worth over $5,825,760.

Certara (CERT) stock rose ~15% on Thursday after Q4 results beat estimates and the company's FY23 outlook range surpassed analysts expectations.Adjusted EPS grew +166.6% Y/Y to $0.16,...If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.4 Apr 2023 ... Certara (CERT), a developer of biosimulation software for drug discovery, dropped Tuesday after Barclays downgraded on valuation concerns.Current stock price of Certara, Inc. (CERT) online. Stock quotes and charts for Certara, Inc. (CERT) on the website of Just2Trade broker.Certara is a former municipality in the district of Lugano in the canton of Ticino in Switzerland. On 14 April 2013 the former municipalities of Bogno, Cadro, Carona, Certara, Cimadera, Valcolla and Sonvico merged into the municipality of Lugano. History.

ETF Watch. Macquarie Introduces Its First U.S. ETFs. Gabe Alpert | Nov 30, 2023. Our CERT ETF report shows the ETFs with the most CERT exposure, the top performing CERT ETFs, and most popular CERT ...

Certara Inc stock has a Value Score of 15, Momentum Score of 49 and Estimate Revisions Score of 29. Comparing Samsara Inc and Certara Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.

Nov 8, 2023 · Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock? Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?Specialized modules are: Simcyp Pediatric. Simcyp® Pediatric Simulator is the industry’s most sophisticated technology for modeling drug performance and determining dosing in neonates, infants, and children. The Simulator contains extensive libraries on demographics, developmental physiology, and the ontogeny of drug elimination pathways.View the latest Corteva Inc. (CTVA) stock price, news, historical charts, analyst ratings and financial information from WSJ.Nov 30, 2023 · Stock analysis for Certara Inc (CERT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Drayton Virkler CERT stock SEC Form 4 insiders trading. Drayton has made over 2 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Drayton exercised 3,990 units of CERT stock worth $57,536 on 31 March 2023.3,990 units of CERT stock worth $57,536 on 31 March 2023.Discover historical prices for CERT stock on Yahoo Finance. View daily, weekly or monthly format back to when Certara, Inc. stock was issued.The estimated Net Worth of William F Feehery is at least $75.5 million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $42,281,189 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.Dec 1, 2023 · A high-level overview of Certara, Inc. (CERT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 13 Sep 2023 ... On the day of the insider's recent sell, shares of Certara Inc were trading for $14.6 apiece, giving the company a market cap of $2.296 billion.William Blair Investment Management LLC grew its position in shares of Certara, Inc. (NASDAQ:CERT - Free Report) by 4.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,026,786 shares of the company's sCertara went public in December 2020, raising $337 million in an IPO. The firm sells biosimulation software and related services to biopharmaceutical firms and regulatory agencies worldwide. CERT ...

Certara Inc’s (CERT) price is currently up 7.73% so far this month. During the month of March, Certara Inc’s stock price has reached a high of $22.02 and a low of $18.20. Over the last year, Certara Inc has hit prices as high as $24.66 and as low as $10.60. Year to date, Certara Inc’s stock is down 31.32%.

CERT Certara, Inc. Stock Price & Overview 2.67K followers $14.64 0.23 ( +1.60%) 4:00 PM 12/01/23 NASDAQ | $USD | Post-Market: $14.64 4:03 PM Summary …Certara, Inc. (NASDAQ: CERT) stock sentiment score is-15 as of the last check on Friday, November 03.That’s a change of -50.00 points from its previous day’s sentiment score of 35.00.-50.00 points from its previous day’s sentiment score of 35.00.Biosimulation can reduce the size of and cost of human trials, the most expensive and time-consuming part of drug development. In some cases, we can eliminate certain human trials completely. More than 2,000 customers worldwide choose us as their partner for biosimulation software and technology-driven services.Real time Certara (CERT) stock price quote, stock graph, news & analysis. Nov 11, 2022 · Certara ( CERT -1.83%), which provides software and technology to help pharmaceutical companies and researchers accelerate drug development, saw its shares rise 37.7% this week. The stock closed ... Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Sifting through countless of stocks in the Software industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Certara Inc because you’re not sure how they measure up, it’s important to compare them ...7 Nov 2022 ... png. Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase. Arsenal will acquire ...

CHPT | Complete ChargePoint Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

ETF Watch. Macquarie Introduces Its First U.S. ETFs. Gabe Alpert | Nov 30, 2023. Our CERT ETF report shows the ETFs with the most CERT exposure, the top performing CERT ETFs, and most popular CERT ...

The institutional investor owned 3,910,996 shares of the company's stock after buying an additional 346,460 shares during the quarter. JPMorgan Chase & Co. owned about 2.45% of Certara worth $84,008,000 at the end of the most recent reporting period. A number of other hedge funds have also added to or reduced their stakes in the stock.Nov 14, 2023 · Certara Inc’s Stock Price as of Market Close. As of November 14, 2023, 4:00 PM, CST, Certara Inc’s stock price was $14.49. Certara Inc is up 11.29% from its previous closing price of $13.02. During the last market session, Certara Inc’s stock traded between $12.99 and $13.66. Currently, there are 159.17 million shares of Certara Inc stock ... Fisker stock price target cut to $1 from $2, strong sell rating reiterated at CFRA. Nov. 14, 2023 at 6:30 a.m. ET by Tomi Kilgore.The estimated Net Worth of William F Feehery is at least $74.9 Million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $41,776,274 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.PBF | Complete PBF Energy Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Nov 22, 2021 · PRINCETON, N.J.—November 22, 2021– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the closing of its underwritten public offering of 10,000,000 shares of its common stock by certain existing stockholders at a public offering price of $31.00 per share. The latest price target for . Certara (NASDAQ: CERT) was reported by Stephens & Co. on April 12, 2023.The analyst firm set a price target for $28.00 expecting CERT to rise to within 12 months (a ...Nov 30, 2023 · Stock analysis for Certara Inc (CERT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Certara stock ( CERT) appears to check all the boxes. Nominated by one of our lovely subscribers, the New Jerzee-based company serves the drug development industry by offering software and services around its biosimulation platform. It claims to compete indirectly with companies like Schrödinger ( SDGR ), which uses a …From Nasdaq : Certara, which provides biosimulation software and services used for drug development, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering. However, this is likely a placeholder for a deal we estimate could raise up to $500 million. The company uses its biosimulation software and technology to ...78.45. +1.10%. 26.59M. View today's Certara Inc stock price and latest CERT news and analysis. Create real-time notifications to follow any changes in the live stock price.Instagram:https://instagram. ares capital corp stockhow to read candle chartsbest oil and gas stocksishares msci eafe Webull offers Certara Inc stock information, including NASDAQ: CERT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CERT stock news, and many more online research tools …Certara (CERT) stock rose ~15% on Thursday after Q4 results beat estimates and the company's FY23 outlook range surpassed analysts expectations.Adjusted EPS grew +166.6% Y/Y to $0.16,... does robinhood have futures tradingqqq dividends Get Certara alerts: Insider Activity at Certara. In other Certara news, major shareholder Avatar Parent L.P. Eqt sold 1,500,000 shares of the company's stock in a transaction dated Tuesday, May 31st. The stock was sold at an average price of $19.00, for a total value of $28,500,000.00. dow jones utility index Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.Conversely, Certara earned 10 cents a share on a non-GAAP basis. Its revenue grew by 14.6% Y/Y to $84.7 million. CERT stock bottomed at $10.60 and closed at $17.72. Certara reiterated its guidance ...